Homeopathy 2013; 102(01): 31-40
DOI: 10.1016/j.homp.2012.10.003
Original Paper
Copyright © The Faculty of Homeopathy 2012

H3N2 homeopathic influenza virus solution modifies cellular and biochemical aspects of MDCK and J774G8 cell lines

Camila Monteiro Siqueira
1   Departamento de Medicamentos-Faculdade de Farmácia, Universidade Federal do Rio de Janeiro – UFRJ, Rio de Janeiro, Brazil
Beatriz Costa
1   Departamento de Medicamentos-Faculdade de Farmácia, Universidade Federal do Rio de Janeiro – UFRJ, Rio de Janeiro, Brazil
Ana Maria Amorim
2   Instituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro – UFRJ, Rio de Janeiro, Brazil
Marta Gonçalves
2   Instituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro – UFRJ, Rio de Janeiro, Brazil
Venício Féo da Veiga
2   Instituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro – UFRJ, Rio de Janeiro, Brazil
Morgana Castelo-Branco
3   Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro – UFRJ, Rio de, Janeiro, Brazil
Christina Takyia
3   Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro – UFRJ, Rio de, Janeiro, Brazil
Patrícia Zancan
4   Departamento de Fármacos-Faculdade de Farmácia, Universidade Federal do Rio de Janeiro – UFRJ, Rio de Janeiro, Brazil
Fernando Portela Câmara
2   Instituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro – UFRJ, Rio de Janeiro, Brazil
José Nelson Couceiro
2   Instituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro – UFRJ, Rio de Janeiro, Brazil
Carla Holandino
1   Departamento de Medicamentos-Faculdade de Farmácia, Universidade Federal do Rio de Janeiro – UFRJ, Rio de Janeiro, Brazil
› Author Affiliations

Subject Editor:
Further Information

Publication History

Received22 September 2011
revised15 October 2012

accepted22 October 2012

Publication Date:
29 December 2017 (online)

Background: Influenza viruses cause highly contagious acute respiratory illnesses with significant mortality, especially among young children, elderly people, and individuals with serious medical conditions. This encourages the development of new treatments for human flu. Biotherapies are diluted solutions prepared from biological products compounded following homeopathic procedures.

Objectives: To develop a biotherapy prepared from the infectious influenza A virus (A/Aichi/2/68 H3N2) and to verify its in vitro response.

Methods: The ultradiluted influenza virus solution was prepared in the homeopathic dilution 30dH, it was termed Influenzinum RC. The cellular alterations induced by this preparation were analyzed by optical and electron microscopy, MTT and neutral red assays. Glycolytic metabolism (PFK-1) was studied by spectrophotometric assay. Additionally, the production of tumor necrosis factor-α (TNF-α) by J774.G8 macrophage cells was quantified by ELISA before and after infection with H3N2 influenza virus and treatment.

Results: Influenzinum RC did not cause cytotoxic effects but induced morphological alterations in Madin–Darby canine kidney (MDCK) cells. After 30 days, a significant increase (p < 0.05) in mitosis rate was detected compared to control. MDCK mitochondrial activity was changed after treatment for 10 and 30 days. Treatment significantly diminished (p < 0.05) PFK-1 activity. TNF-α in biotherapy-stimulated J774.G8 macrophages indicated a significant (p < 0.05) increase in this cytokine when the cell supernatant was analyzed.

Conclusion: Influenzinum RC altered cellular and biochemical features of MDCK and J774G8 cells.

  • References

  • 1 www.who.int/topics/influenza/en/.
  • 2 www.who.int/entity/csr/disease/swineflu/en.
  • 3 http://new.paho.org/hq/index.php?option=com_content&task=view&id=3154&Item id = 2498&lang=enlink.
  • 4 Hayden F.G. Antivirals for influenza: historical perspectives and lessons learned. Antivir Res 2006; 71 (2–): 372-378.
  • 5 Monto A.S., McKimm-Breschkin J.L., Macken C. et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 2006; 50 (07) 2395-2402.
  • 6 Prober C.G. Antiviral therapy for influenza virus infection. Semin Pediatr Infect Dis 2002; 13: 31-39.
  • 7 Forleo-Neto E., Halker E., Santos V.J., Paiva T.M., Toniolo-Neto J. Influenza. Rev Soc Bras Med Trop 2003; 36 (02) 267-274.
  • 8 Gomes M.L., Macedo A.M., Pena S.D., Chiari E. Genetic relationships between Trypanosoma cruzi strains isolated from chronic patients in southern Brazil as revealed by RAPD and SSR-PCR analysis. Acta Trop 1998; 69 (02) 99-109.
  • 9 Gomes M.L., Macedo A.M., Vago A.R., Pena S.D., Galvão L.M., Chiari E. Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. Exp Parasitol 1998; 88: 28-33.
  • 10 Almeida R.L., Campos M.C., Herrera H.M., Bonamin L.V., da Fonseca A.H. Effects of homeopathy in mice experimentally infected with Trypanosoma cruzi . Homeopathy 2008; 97 (02) 65-69.
  • 11 Queiroz A.O., Xavier S.C.C., Faria K.G., Bernardo R.R., Leitão T.C.A. Avaliação do bioterápico Trypanosoma cruzi 30 DH: Um Estudo In Vivo . Cult Homeopát 2006; 17: 9-13.
  • 12 Silva A.M.C.P., Schwartz F.F., Cardoso M.V., César A.T., Sollero P.A. Uso de bioterápico de Mycoplasma spp. em rebanho bovino leiteiro. Cult Homaopát 2005; 4 (13) 43-47.
  • 13 Brener Z., Andrade Z.A., Netto M.B. Trypanosoma cruzi e doença de Chagas. 2nd edn. Rio de Janeiro: Guanabara Koogan; 2000. p. 431.
  • 14 Costa B.G.B., Siqueira C.M., Aquino C.L. et al. Development of a new biotherapy of Candida albicans to the treatment of oral candidiasis. In: 63rd Congress of the Liga Medicorum Homeopathica Internationalis (LMHI) 2008. 63 1-8.
  • 15 Aquino C.L., Barbosa G.M., Barbosa G.M. et al. High dilutions of Euphorbia tirucalli L. (AVELOZ) modify the viability and glycolytic metabolism of cell lines. Int J High Dilution Res 2008; 7: 132-139.
  • 16 Varricchio M.C.B.N., Pereira C., Gomes T. et al. Chronic toxicological effects of high diluted solutions of Aveloz (Euphorbia tirucalli L.) on healthy mice: a preliminary study. Int J High Dilution Res 2008; 7 (25) 174-178.
  • 17 Aleixo D.L., Ferraz F.N., de Melo C.S. et al. Changes of RAPD profiles of Trypanosoma cruzi II with Canova and Benznidazole. Homeopathy 2008; 97: 59-64.
  • 18 Cavalcanti A.M., Rocha L.M., Carillo Jr. R., Lima L.U., Lugon J.R. Effects of homeopathic treatment on pruritus of haemodialysis patients: a randomised placebo-controlled double-blind trial. Homeopathy 2003; 92 (04) 177-181.
  • 19 Ferley J.P., Zmirou D., D'Adhemar D., Balducci F. A controlled evaluation of a homoeopathic preparation in the treatment of influenza like syndromes. Br J Clin Pharmacol 1989; 27: 329-335.
  • 20 Papp R., Schuback G., Beck E. et al. Oscillococcinum in patients with influenza-like syndromes: a placebo-controlled double-blind evaluation. Br Homeopath J 1998; 87: 69-76.
  • 21 Farmacopéia Homeopática Brasileira. 3rd edn. Brasil: Ministério da Saúde; 2011.
  • 22 Clausen J., van Wijk R., Albrecht H. Infection models in basic research on homeopathy. Homeopathy 2010; Oct 99 (04) 263-270.
  • 23 Ferraz F.N., Simoni G.K., do Nascimento A. et al. Different forms of administration of biotherapy 7dH in mice experimentally infected by Trypanosoma cruzi produce different effects. Homeopathy 2011; Oct 100 (04) 237-243.
  • 24 Vickers, Smith. Homeopathic oscillococcinum for preventing and treating influenza and influenza-like syndromes. Cochrane Database Syst Rev 2006; 3.
  • 25 Fontes O.L., Severino P., Chaud M.V. et al. Ação terapêutica do medicamento homeopático em ratas com infecção urinária por Escherichia coli . Cult Hom 2005; 13: 9-18.
  • 26 Costa R.A. Homeopathies atualizada. 3rd edn. Petrópolis: Ed Vozes; 1988. p. 268.
  • 27 Costa R.A. Nosódios Vivos. 1st edn. Rio de Janeiro: Farmácia Homeopática Átomo Ltda.; 2002. p. 95.
  • 28 Barros J.J.F., Alvianoc D.S., da Silva M.H. et al. Characterization of sialidase from an influenza A (H3N2) virus strain: kinetic parameters and substrate specificity. Intervirology 2003; 46: 199-206.
  • 29 Holandino C., Veiga V.F., Rodrigues M.L., Morales M.M., Capella M.A.M., Alviano C.S. Direct current decreases cell viability but not P-glycoprotein expression and function in human multidrug resistant leukaemic cell. Bioelectromagnetics 2001; 22: 470-478.
  • 30 Finter N.B. Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays. J Gen Virol 1969; 5: 419-427.
  • 31 Rogero S.O., Lugão A.B., Ikeda T.I., Cruz A.S. Teste in vitro de Citotoxicidade: estudo comparativo entre duas metodologias. Mater Res 2003; 6 (03) 317-320.
  • 32 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65 (1,2); 55-63.
  • 33 Veiga V.F., Nimrichter L., Teixeira C.A. et al. Exposure of human leukemic cells to direct electric current: generation of toxic compounds inducing cell death by different mechanisms. Cell Biochem Biophys 2005; 42: 61-74.
  • 34 Muehlbauer P.A., Schuler M.J. Measuring the mitotic index in chemically-treated human lymphocyte cultures by flow cytometry. Mutat Res 2003; 537: 117-130.
  • 35 Weller P.F., Dvorak A.M. Lipid bodies: intracellular sites for eicosanoid formation. J Allergy Clin Immunol 1994; 94: 1151-1156.
  • 36 Martin S., Parton R.G. Caveolin, cholesterol and lipid bodies. Cell Dev Biol 2005; 16: 163-174.
  • 37 Prophet E.B., Mills R. Laboratory methods in histotechnology. Ed. American Registry of Pathology Washington: Armed Forces Institute of Pathology; 1994. p. 279.
  • 38 Coelho W.S., Costa K.C., Sola-Penna M. Serotonin stimulates mouse skeletal muscle 6-phosphofruto-1-kinase through tyrosine-phosphorylation of the enzyme altering its intracellular localization. Mol Genet Metab 2007; 92: 364-370.
  • 39 Wells M.A., Albrecht P., Sylvester D., Francis A.E. Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro . Infect Immun 1978; 22 (03) 758-762.
  • 40 Coligan J.E. In: Current Protocols in Immunology, 1, chap. 6. 1995. John Wiley & Sons, Inc.;
  • 41 Bildet J., Guyot M., Bonini F., Grignon M.C., Poitevin B., Quilichini R. The effect of dilutions of Apis mellifica and Apium virus on ultraviolet light-induced erythema in the guinea pig. Ann Pharm Fr 1989; 47 (01) 24-32.
  • 42 Bonamim L.V., Martinho K.S., Nina A.L., Caviglia F., Do Rio R.G. Very high dilutions of dexamethasone inhibit its pharmacological effects in vivo . Br Homeopath J 2001; 90 (04) 198-203.
  • 43 Poitevein B., Davenas E., Benveniste J. In vitro immunological degranulation of human basophils is modulated by lung histamine and Apis mellifica. Br J Clin Pharmacol 1998; 25 (04) 439-444.
  • 44 Mesquita L.P. Homeopathy and physiotherapy with special reference to osteoarthropathy. Br Homeopath J 1998; 76 (01) 16-18.
  • 45 Witt C.M., Bluth M., Albrecht H. et al. The in vitro evidence for an effect of high homeopathic potencies – a systematic review of the literature. Complement Ther Med 2007; 15: 128-138.
  • 46 Marques R.M., Cavalca P.A.M., Casali V.W.D., Bonato C.M. Efeito de medicamentos homeopáticos na germinação de sementes de soja. Encontro Internacional de Produção Científica Cesumar (VI EPCC). Centro Universitário de Maringá; 2009.
  • 47 Endler P.C., Thieves K., Reich C. et al. Repetitions of fundamental research models for homeopathically prepared dilutions beyond 10−23: a bibliometric study. Homeopathy 2010; 99: 25-36.
  • 48 Elia V., Baiano S., Duro I. et al. Permanent physical chemistry properties of extremely diluted aqueous solutions of homeopathic medicines. Homeopathy 2004; 93: 144-150.
  • 49 Elia V., Marchese M., Montanino M. et al. Hydrohysteretic phenomena of extremely diluted solutions induced by mechanical treatments: a calorimetric and conductometric study at 25°C. J Solut Chem 2005; 34 (08) 947-960.
  • 50 Elia V., Elia L., Cacace P. et al. The extremely diluted solutions as multi-variable systems: a study of calorimetric and conductometric behaviour as a function of the parameter time. J Therm Anal Calorim 2006; 84 (02) 317-323.
  • 51 Elia V., Napoli E., Germano R. The “Memory of Water”: an almost deciphered enigma. Dissipative structures in extremely dilute aqueous solutions. Homeopathy 2007; 96: 163-169.
  • 52 Rey L. Thermoluminescence of ultra high dilutions of lithium chloride and sodium chloride. Physica A 2003; 323: 67-74.
  • 53 Van Wijk R., Bosman S., Van Wijk E.P. Thermoluminescence in ultra-high dilution research. J Altern Complement Med 2006; 12 (05) 437-443.
  • 54 Lobyshev V.I., Shikhlinskaya R.E., Ryzhikov B.D. Experimental evidence for intrinsic luminescence of water. J Mol Liq 1999; 82: 73-81.
  • 55 Samal S., Geckeler K.E. Unexpected solute aggregation in water on dilution. Chem Commun 2001; 21: 2224-2225.
  • 56 Walach H., Van Asseldonk T., Bourkas P. et al. Electric measurement of ultra-high dilutions – a blinded controlled experiment. Br Homeopath J 1988; 87: 3-12 http://www.sciencedirect.com/science/article/pii/S0007078598800033-fn2.
  • 57 Klimek W., Yan Y., Tschulakow A.V. A new approach to the memory of water. Homeopathy 2005; 94: 241-247.
  • 58 Rao M.L., Roy R., Bell I.R., Hoover R. The defining role of structure (including eptiaxy) in the plausibility of homeopathy. Homeopathy 2007; 96: 175-182.
  • 59 Meira D.D., Marinho-Carvalho M.M., Teixeira C.A.A. et al. Clotrimazole decreases the viability of MCF-7 human breast cancer cells through alteration of cytoskeleton morphology and cytoskeleton associated glycolytic enzymes. Mol Genet Metab 2005; 84: 354-362.
  • 60 El-Bacha T., de Freitas M.S., Sola-Penna M. Cellular distribution of phosphofructokinase activity and implications to metabolic regulation in human breast cancer. Molecular Genetics and Metabolism 2003; 79: 294-299.
  • 61 Oliveira C.C., de Oliveira S.M., Godoy L.M., Gabardo J., Buchi Dde F. Canova, a Brazilian medical formulation, alters oxidative metabolism of mice macrophages. J Infect 2006; 52: 420-432.
  • 62 Danninger T., Gallenberger K., Kraeling J. Immunologic changes in healthy probands and HIV infected patients after oral administration of Staphylococcus aureus 12C: a pilot study. Br Homeopath J 2000; 89: 106-115.
  • 63 Guimarães F.S.F., Andrade L.F., Martins S. et al. In vitro and in vivo anticancer properties of a Calcarea carbonica derivative complex (M8) treatment in a murine melanoma model. BMC Cancer 2010; 10: 113.